DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Lantheus
LNTH
Cars.com
CARS
Constellation Brands
STZ
eBay
EBAY
US Stock MarketDetailed Quotes
CMPX Compass Therapeutics
- 2.690
- +0.070+2.67%
Close Mar 7 16:00 ET
- 2.690
- 0.0000.00%
Post 20:01 ET
371.98MMarket Cap-7.47P/E (TTM)
2.790High2.600Low573.75KVolume2.610Open2.620Pre Close1.54MTurnover0.69%Turnover RatioLossP/E (Static)138.28MShares4.08052wk High2.97P/B224.95MFloat Cap0.76552wk Low--Dividend TTM83.63MShs Float8.800Historical High--Div YieldTTM7.25%Amplitude0.765Historical Low2.682Avg Price1Lot Size
About Compass Therapeutics Company
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.
Company Profile
SymbolCMPX
Company NameCompass Therapeutics
Listing DateNov 2, 2021
Issue Price3.50
Founded2014
CEODr. Thomas J. Schuetz, M.D.,PhD
MarketNASDAQ
Employees35
Fiscal Year Ends12-31
Address80 Guest Street,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02135
Phone1-617-500-8099
Company Executives
- Name
- Position
- Salary
- Dr. Thomas J. Schuetz, M.D.,PhD
- President, Chief Executive Officer and Vice Chairman of the Board
- 4.87M
- Barry Shin, J.D.,M.B.A.
- Chief Financial Officer
- --
- Neil Lerner, C.P.A.
- Vice President, Finance and Principal Accounting Officer
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Chairman of the Board
- 222.63K
- Ellen V. Chiniara, J.D.
- Independent Director
- 163.42K
- Richard S. Lindahl
- Independent Director
- 147.92K
- James P. Boylan, M.B.A.
- Independent Director
- 45.00K
- Dr. Philip J. Ferneau, J.D.
- Independent Director
- 193.02K
- Dr. Mary Ann Gray,PhD
- Independent Director
- 163.42K